APO Research
Talk to an analyst

APO RESEARCH · REPORT

Japanese Encephalitis Inactivated Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Japanese Encephalitis Inactivated Vaccine Industry Growth and Trends Forecast to 2032

29 December 202599 pages

Choose your research edition.

Industry ResearchJapanese Encephalitis Inactivated Vaccine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Japanese Encephalitis Inactivated Vaccine Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Japanese Encephalitis Inactivated Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Japanese Encephalitis Inactivated Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Japanese Encephalitis Inactivated Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Japanese Encephalitis Inactivated Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Japanese Encephalitis Inactivated Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Japanese Encephalitis Inactivated Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Japanese Encephalitis Inactivated Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Japanese Encephalitis Inactivated Vaccine include Liaoning Chengda Biological Co., Ltd, Lanzhou Institute of Biological Products Co., Ltd, Chengdu Institute of Biological Products Co., Ltd, Beijing Institute of Biological Products Co., Ltd, Valneva, Sanofi Pasteur and Biken, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Japanese Encephalitis Inactivated Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Japanese Encephalitis Inactivated Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Japanese Encephalitis Inactivated Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Japanese Encephalitis Inactivated Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Japanese Encephalitis Inactivated Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Japanese Encephalitis Inactivated Vaccine Market by Company

Liaoning Chengda Biological Co., Ltd

Lanzhou Institute of Biological Products Co., Ltd

Chengdu Institute of Biological Products Co., Ltd

Beijing Institute of Biological Products Co., Ltd

Valneva

Sanofi Pasteur

Biken

Japanese Encephalitis Inactivated Vaccine Segment by Type

Adult

Child

Japanese Encephalitis Inactivated Vaccine Segment by Application

Hospital

Clinic

Japanese Encephalitis Inactivated Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Japanese Encephalitis Inactivated Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Japanese Encephalitis Inactivated Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Japanese Encephalitis Inactivated Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Japanese Encephalitis Inactivated Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Japanese Encephalitis Inactivated Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Adult Table 2. Major Company of Child Table 3. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Japanese Encephalitis Inactivated Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Japanese Encephalitis Inactivated Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Japanese Encephalitis Inactivated Vaccine Industry Trends Table 25. Japanese Encephalitis Inactivated Vaccine Industry Drivers Table 26. Japanese Encephalitis Inactivated Vaccine Industry Opportunities and Challenges Table 27. Japanese Encephalitis Inactivated Vaccine Industry Restraints Table 28. Global Japanese Encephalitis Inactivated Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Japanese Encephalitis Inactivated Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Japanese Encephalitis Inactivated Vaccine Sales Share by Company (2021-2026) Table 32. Global Japanese Encephalitis Inactivated Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Japanese Encephalitis Inactivated Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Japanese Encephalitis Inactivated Vaccine Major Company Production Sites and Headquarters Table 35. Global Japanese Encephalitis Inactivated Vaccine Company, Product Type & Application Table 36. Global Japanese Encephalitis Inactivated Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Japanese Encephalitis Inactivated Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Japanese Encephalitis Inactivated Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Japanese Encephalitis Inactivated Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Japanese Encephalitis Inactivated Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Japanese Encephalitis Inactivated Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Japanese Encephalitis Inactivated Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Japanese Encephalitis Inactivated Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Japanese Encephalitis Inactivated Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Japanese Encephalitis Inactivated Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Japanese Encephalitis Inactivated Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Liaoning Chengda Biological Co., Ltd Company Information Table 72. Liaoning Chengda Biological Co., Ltd Business Overview Table 73. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 75. Liaoning Chengda Biological Co., Ltd Recent Development Table 76. Lanzhou Institute of Biological Products Co., Ltd Company Information Table 77. Lanzhou Institute of Biological Products Co., Ltd Business Overview Table 78. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 80. Lanzhou Institute of Biological Products Co., Ltd Recent Development Table 81. Chengdu Institute of Biological Products Co., Ltd Company Information Table 82. Chengdu Institute of Biological Products Co., Ltd Business Overview Table 83. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 85. Chengdu Institute of Biological Products Co., Ltd Recent Development Table 86. Beijing Institute of Biological Products Co., Ltd Company Information Table 87. Beijing Institute of Biological Products Co., Ltd Business Overview Table 88. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 90. Beijing Institute of Biological Products Co., Ltd Recent Development Table 91. Valneva Company Information Table 92. Valneva Business Overview Table 93. Valneva Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Valneva Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 95. Valneva Recent Development Table 96. Sanofi Pasteur Company Information Table 97. Sanofi Pasteur Business Overview Table 98. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 100. Sanofi Pasteur Recent Development Table 101. Biken Company Information Table 102. Biken Business Overview Table 103. Biken Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Biken Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 105. Biken Recent Development Table 106. North America Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. North America Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 108. North America Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2021-2026) Table 109. North America Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 110. North America Japanese Encephalitis Inactivated Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. North America Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Japanese Encephalitis Inactivated Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Japanese Encephalitis Inactivated Vaccine Market Share by Country (2021-2026) Table 114. North America Japanese Encephalitis Inactivated Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Japanese Encephalitis Inactivated Vaccine Market Share Forecast by Country (2027-2032) Table 116. Europe Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 118. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2021-2026) Table 119. Europe Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 120. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Japanese Encephalitis Inactivated Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Japanese Encephalitis Inactivated Vaccine Market Share by Country (2021-2026) Table 124. Europe Japanese Encephalitis Inactivated Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Japanese Encephalitis Inactivated Vaccine Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 128. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 130. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Market Share by Country (2021-2026) Table 134. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Market Share Forecast by Country (2027-2032) Table 136. Latin America Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Latin America Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 138. Latin America Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2021-2026) Table 139. Latin America Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 140. Latin America Japanese Encephalitis Inactivated Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Japanese Encephalitis Inactivated Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Japanese Encephalitis Inactivated Vaccine Market Share by Country (2021-2026) Table 144. Latin America Japanese Encephalitis Inactivated Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Japanese Encephalitis Inactivated Vaccine Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 148. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Share by Country (2021-2026) Table 154. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Japanese Encephalitis Inactivated Vaccine Distributors List Table 159. Japanese Encephalitis Inactivated Vaccine Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Japanese Encephalitis Inactivated Vaccine Image Figure 2. Global Japanese Encephalitis Inactivated Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Japanese Encephalitis Inactivated Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Japanese Encephalitis Inactivated Vaccine Sales (2021-2032) & (K Units) Figure 5. Adult Image Figure 6. Global Adult Sales YoY Growth (2021-2032) & (K Units) Figure 7. Child Image Figure 8. Global Child Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Japanese Encephalitis Inactivated Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Japanese Encephalitis Inactivated Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Japanese Encephalitis Inactivated Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Japanese Encephalitis Inactivated Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Japanese Encephalitis Inactivated Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Japanese Encephalitis Inactivated Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Japanese Encephalitis Inactivated Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Japanese Encephalitis Inactivated Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Japanese Encephalitis Inactivated Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Japanese Encephalitis Inactivated Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Japanese Encephalitis Inactivated Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Japanese Encephalitis Inactivated Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Japanese Encephalitis Inactivated Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Japanese Encephalitis Inactivated Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Japanese Encephalitis Inactivated Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Japanese Encephalitis Inactivated Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Japanese Encephalitis Inactivated Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Japanese Encephalitis Inactivated Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Japanese Encephalitis Inactivated Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Adult
  • Child
Applications
  • Hospital
  • Clinic
Companies covered
  • Liaoning Chengda Biological Co., Ltd
  • Lanzhou Institute of Biological Products Co., Ltd
  • Chengdu Institute of Biological Products Co., Ltd
  • Beijing Institute of Biological Products Co., Ltd
  • Valneva
  • Sanofi Pasteur
  • Biken

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Japanese Encephalitis Inactivated Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Japanese Encephalitis Inactivated Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Japanese Encephalitis Inactivated Vaccine Market by Type
  6. 1.3.1 Adult
  7. 1.3.2 Child
  8. 1.4 Global Japanese Encephalitis Inactivated Vaccine Market Size by Type
  9. 1.4.1 Global Japanese Encephalitis Inactivated Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Japanese Encephalitis Inactivated Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Japanese Encephalitis Inactivated Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Japanese Encephalitis Inactivated Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Japanese Encephalitis Inactivated Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Japanese Encephalitis Inactivated Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Japanese Encephalitis Inactivated Vaccine Industry Trends
  2. 2.2 Japanese Encephalitis Inactivated Vaccine Industry Drivers
  3. 2.3 Japanese Encephalitis Inactivated Vaccine Industry Opportunities and Challenges
  4. 2.4 Japanese Encephalitis Inactivated Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Japanese Encephalitis Inactivated Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Japanese Encephalitis Inactivated Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Japanese Encephalitis Inactivated Vaccine Price (2021-2026)
  4. 3.4 Global Japanese Encephalitis Inactivated Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Japanese Encephalitis Inactivated Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Japanese Encephalitis Inactivated Vaccine Company, Product Type & Application
  7. 3.7 Global Japanese Encephalitis Inactivated Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Japanese Encephalitis Inactivated Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Japanese Encephalitis Inactivated Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Japanese Encephalitis Inactivated Vaccine Tier 1, Tier 2, and Tier 3
4 Japanese Encephalitis Inactivated Vaccine Regional Status and Outlook
  1. 4.1 Global Japanese Encephalitis Inactivated Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Japanese Encephalitis Inactivated Vaccine Historic Market Size by Region
  3. 4.2.1 Global Japanese Encephalitis Inactivated Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Japanese Encephalitis Inactivated Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Japanese Encephalitis Inactivated Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Japanese Encephalitis Inactivated Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Japanese Encephalitis Inactivated Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Japanese Encephalitis Inactivated Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Japanese Encephalitis Inactivated Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Japanese Encephalitis Inactivated Vaccine by Application
  1. 5.1 Japanese Encephalitis Inactivated Vaccine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Japanese Encephalitis Inactivated Vaccine Market Size by Application
  5. 5.2.1 Global Japanese Encephalitis Inactivated Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Japanese Encephalitis Inactivated Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Japanese Encephalitis Inactivated Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Japanese Encephalitis Inactivated Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Japanese Encephalitis Inactivated Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Japanese Encephalitis Inactivated Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Liaoning Chengda Biological Co., Ltd
  2. 6.1.1 Liaoning Chengda Biological Co., Ltd Company Information
  3. 6.1.2 Liaoning Chengda Biological Co., Ltd Business Overview
  4. 6.1.3 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  6. 6.1.5 Liaoning Chengda Biological Co., Ltd Recent Developments
  7. 6.2 Lanzhou Institute of Biological Products Co., Ltd
  8. 6.2.1 Lanzhou Institute of Biological Products Co., Ltd Company Information
  9. 6.2.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
  10. 6.2.3 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  12. 6.2.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
  13. 6.3 Chengdu Institute of Biological Products Co., Ltd
  14. 6.3.1 Chengdu Institute of Biological Products Co., Ltd Company Information
  15. 6.3.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
  16. 6.3.3 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  18. 6.3.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
  19. 6.4 Beijing Institute of Biological Products Co., Ltd
  20. 6.4.1 Beijing Institute of Biological Products Co., Ltd Company Information
  21. 6.4.2 Beijing Institute of Biological Products Co., Ltd Business Overview
  22. 6.4.3 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  24. 6.4.5 Beijing Institute of Biological Products Co., Ltd Recent Developments
  25. 6.5 Valneva
  26. 6.5.1 Valneva Company Information
  27. 6.5.2 Valneva Business Overview
  28. 6.5.3 Valneva Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Valneva Japanese Encephalitis Inactivated Vaccine Product Portfolio
  30. 6.5.5 Valneva Recent Developments
  31. 6.6 Sanofi Pasteur
  32. 6.6.1 Sanofi Pasteur Company Information
  33. 6.6.2 Sanofi Pasteur Business Overview
  34. 6.6.3 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product Portfolio
  36. 6.6.5 Sanofi Pasteur Recent Developments
  37. 6.7 Biken
  38. 6.7.1 Biken Company Information
  39. 6.7.2 Biken Business Overview
  40. 6.7.3 Biken Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Biken Japanese Encephalitis Inactivated Vaccine Product Portfolio
  42. 6.7.5 Biken Recent Developments
7 North America by Country
  1. 7.1 North America Japanese Encephalitis Inactivated Vaccine Sales by Country
  2. 7.1.1 North America Japanese Encephalitis Inactivated Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Japanese Encephalitis Inactivated Vaccine Market Size by Country
  6. 7.2.1 North America Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Japanese Encephalitis Inactivated Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Japanese Encephalitis Inactivated Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Japanese Encephalitis Inactivated Vaccine Sales by Country
  2. 8.1.1 Europe Japanese Encephalitis Inactivated Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Japanese Encephalitis Inactivated Vaccine Market Size by Country
  6. 8.2.1 Europe Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Japanese Encephalitis Inactivated Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Japanese Encephalitis Inactivated Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Japanese Encephalitis Inactivated Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Japanese Encephalitis Inactivated Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Japanese Encephalitis Inactivated Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Japanese Encephalitis Inactivated Vaccine Sales by Country
  2. 10.1.1 South America Japanese Encephalitis Inactivated Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Japanese Encephalitis Inactivated Vaccine Market Size by Country
  6. 10.2.1 South America Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Japanese Encephalitis Inactivated Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Japanese Encephalitis Inactivated Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Japanese Encephalitis Inactivated Vaccine Value Chain Analysis
  2. 12.1.1 Japanese Encephalitis Inactivated Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Japanese Encephalitis Inactivated Vaccine Production Mode & Process
  7. 12.2 Japanese Encephalitis Inactivated Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Japanese Encephalitis Inactivated Vaccine Distributors
  10. 12.2.3 Japanese Encephalitis Inactivated Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst